{"id":"W4413122220","doi":"10.3390/curroncol32080444","title":"Multidisciplinary Practical Guidance for Implementing Adjuvant CDK4/6 Inhibitors for Patients with HR-Positive, HER2-Negative Early Breast Cancer in Canada","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Grand River Hospital; Ottawa Hospital; Dr. H. Bliss Murphy Cancer Centre; Jewish General Hospital; University of Toronto; Mount Sinai Hospital; Sunnybrook Health Science Centre","funders":"Daiichi Sankyo Europe; Eli Lilly Canada; Ipsen; Astellas Pharma; Eisai; Incyte; Allergan; Helsinn; Genomic Health; Seagen; Gilead Sciences; Amgen; Pfizer; Myriad Genetics; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Tolerability; Adverse effect; Breast cancer; Multidisciplinary approach; Quality of life (healthcare); Clinical trial; Oncology; Metastatic breast cancer; Intensive care medicine; Adjuvant; Advance care planning; Internal medicine; Cancer; Palliative care; Nursing","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013029,0.0002306368,0.0004927272,0.0001188999,0.000114092,0.000006535807,0.00008013265,0.00006215482,0.0000495303],"category_scores_gemma":[0.0001198647,0.0001932239,0.00005572403,0.0002435967,0.0001098684,0.0001163487,0.0000851716,0.0002227993,7.235641e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002694644,"about_ca_system_score_gemma":0.003213448,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.06174785,"about_ca_topic_score_gemma":0.5537918,"domain_scores_codex":[0.9983242,0.00005866747,0.0004092884,0.000457057,0.000173596,0.0005771978],"domain_scores_gemma":[0.9985402,0.0005049377,0.0002530784,0.000160756,0.0004300617,0.0001110129],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004760206,0.0005866095,0.7837034,0.0002590509,0.0001431153,0.000009032868,0.0005227937,0.00001939401,0.00007705038,0.0001833796,0.001041641,0.2086943],"study_design_scores_gemma":[0.01359494,0.0008085966,0.9590111,0.001072935,0.0001406605,0.000007723948,0.0008180271,0.0003743522,0.0004761312,0.000215906,0.02324229,0.000237331],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9811763,0.0006786413,0.005130363,0.005482883,0.001400549,0.004429979,0.001234468,0.00004019012,0.0004266851],"genre_scores_gemma":[0.9915266,0.00001832463,0.006008442,0.0001553659,0.0001995221,0.001783896,0.00006405696,0.00005038701,0.0001934123],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4920439,"threshold_uncertainty_score":0.9445,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03220749072323967,"score_gpt":0.4056603800270666,"score_spread":0.3734528893038269,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}